Full-Time

Training Specialist

Aseptic Operations

Confirmed live in the last 24 hours

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Senior

Somerset County, NJ, USA

Part of the Technical Operations team based in Raritan, NJ.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • A minimum of a Bachelor’s Degree in Science, Information Science or equivalent experience is required.
  • A minimum of 5 years relevant work experience is required.
  • Candidate must have experience working within an aseptic manufacturing facility, preferably in QA or QA Micro, training, project management, learning management systems, or quality systems.
  • Knowledge of cGMP regulations and FDA/EU guidance related to manufacturing of cell based products as well as knowledge of Good Tissue Practices.
  • Experience with training methodology, adult learning theory, scheduling, and training plans.
  • LMS experience
Responsibilities
  • Leads and owns the Aseptic training, qualification, requalification schedule weekly.
  • Develops end-to-end aseptic training plans for new and current operators.
  • Assigns curricula to new and current aseptic operators according to learning journey as needed.
  • Maintains tracking and scheduling of yearly requalification’s.
  • Tracks progress of Aseptic Operators and ensures on time completion of training.
  • Track and maintains KPI’s that impact site production capacity.
  • Plan and meet site capacity goals by ensure the sufficient quality and quantity of aseptic operators.
  • Collaborates and stays connected with Operations and QA Micro.
  • Works on aseptic training improvement projects that make a positive impact on the APQ Program.
  • Collaborates with Process Engineering, Technical Support, Planning, and other advanced areas on implementation projects that may impact APQ program.
  • Identifies APQ needs and expectations, monitors progress, addresses and resolves gaps in training requirements for Operations and other support areas.
  • Elevated access level in LMS to capture training compliance in real-time, assign training as needed, and run reports.
  • Supports the maintenance and reporting of QA training metrics.

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates within the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's own cells to combat cancer. Unlike many competitors, Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments. Their goal is to provide effective treatments for hard-to-treat diseases through innovative cell therapy solutions.

Company Stage

IPO

Total Funding

$146.4M

Headquarters

Franklin Township, New Jersey

Founded

2014

Growth & Insights
Headcount

6 month growth

20%

1 year growth

47%

2 year growth

106%
Simplify Jobs

Simplify's Take

What believers are saying

  • Legend Biotech's recent European Commission approval for CARVYKTI® positions it as a leader in the multiple myeloma treatment market.
  • Strategic partnerships, such as the one with MaxCyte, enhance Legend Biotech's capabilities in cell engineering and expand its technological reach.
  • The company's commitment to transparency and investor relations, demonstrated through regular financial updates, fosters investor confidence and long-term stability.

What critics are saying

  • The competitive landscape in cell therapy and personalized medicine is intense, requiring continuous innovation to maintain market position.
  • Regulatory hurdles and the need for extensive clinical trials can delay the commercialization of new therapies, impacting revenue streams.

What makes Legend Biotech unique

  • Legend Biotech's technology-agnostic approach allows it to explore multiple innovative therapies, unlike competitors who may focus on a single technology.
  • The company's comprehensive business model, from discovery to commercialization, ensures control over the entire treatment lifecycle, providing a competitive edge.
  • Legend Biotech's strong focus on CAR-T therapies, particularly for hematological malignancies and solid tumors, sets it apart in the personalized medicine sector.

Help us improve and share your feedback! Did you find this helpful?